We therefore examined the possibility that L1 signaling involves the NF-κB pathway and have shown that L1 confers its cancer promoting properties in CRC cells by activating the NF-κB pathway such that blocking NF-κB signaling eliminated the ability of L1 to confer its metastatic potential [39]. The gene discussed is NFKB1; the disease is colorectal carcinoma.